Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study.
Impact of obefazimod on viral persistence, inflammation, and immune activation in people with HIV on suppressive antiretroviral therapy.
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis.
Impact of antibiotic treatment on the gut microbiome and its resistome in hematopoietic stem cell transplant recipients.
The Role of Late Presenters in HIV-1 Transmission Clusters in Europe.
Oral and intravenous 1'-cyano-substituted adenosine-like antivirals for early COVID-19.
Vagus Nerve Dysfunction in the Post-COVID-19 Condition: a pilot cross sectional study.
"The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis".
Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels.
A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes.